Merck buying Acceleron Pharma in $11.5B deal

Merck will spend about $11.5 billion to buy Acceleron Pharma and its potential treatment for high blood pressure in vessels that connect the lungs heart.

Reports had suggested the countries were set to follow the example of Greece, which effectively suspended biometric checks for UK nationals....
0 comments:
Post a Comment